The latest closing stock price for Neumora Therapeutics as of March 28, 2025 is 1.03.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-937 today, roughly -1 times their original investment - a -74.82% compound annual growth rate over 2 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 17.19, which is 1568.9% above the current share price.
The Neumora Therapeutics 52-week low stock price is 1.02, which is 1% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 9.05.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-937 today, roughly -1 times their original investment - a -74.82% compound annual growth rate over 2 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 17.19, which is 1568.9% above the current share price.
The Neumora Therapeutics 52-week low stock price is 1.02, which is 1% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 9.05.